Discover the causes, diagnosis, and benefits of genetic testing for NOR Polyagglutination Syndrome, a rare blood disorder affecting red blood cells and overall health.
Clouding of the lens nucleus from birth or early childhood defines this congenital cataract. Reported CRYBB1 and GJA3 mutations and carrier screening are set out.
Underdevelopment of the cerebellum, pons and olivary nuclei in OPCH affects balance and motor skills; MRI with CASK, TSEN54, RARS2 and VRK1 testing aids diagnosis.
Seizures, developmental delay and hormonal imbalance can accompany underdeveloped optic nerves; whole exome sequencing can identify FOXA2 mutations.
Low bone mass before age 50 can trace to mutations such as a heterozygous WNT1 variant, and diet, exercise and carbonated drinks are covered alongside genetic testing.
Serological typing can miss this rare blood group, in which FUT1 mutations reduce ABO antigens on red cells and raise risks during transfusion and transplantation.
Cold or exertion can trigger muscle stiffness, while high blood potassium accompanies bouts of weakness; both conditions stem from mutations in the SCN4A gene.
Developmental delay, hearing loss, vision problems and liver dysfunction follow faulty peroxisomes; PBD3B sits in the Zellweger spectrum and PEX6 variants are reported.